CLINICAL_TRIALS trial_result · 2024-10-09

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity [Phase 2]

Pfizer conducted a Phase 2 trial to evaluate the efficacy and safety of PF-06882961 in adults with obesity; results for the study have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pfizer | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2024-10-09